Olga Blomberg

984 total citations
9 papers, 583 citations indexed

About

Olga Blomberg is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Olga Blomberg has authored 9 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Olga Blomberg's work include Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (2 papers) and Immune cells in cancer (2 papers). Olga Blomberg is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (2 papers) and Immune cells in cancer (2 papers). Olga Blomberg collaborates with scholars based in Netherlands, United States and Germany. Olga Blomberg's co-authors include Lorenzo Spagnuolo, Karin E. de Visser, Stephanie K. Dougan, Hidde L. Ploegh, Jessica R. Ingram, Michael Dougan, Camilo Espinosa, Lestat R. Ali, Mohammad Rashidian and Novalia Pishesha and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Olga Blomberg

9 papers receiving 580 citations

Peers

Olga Blomberg

IMMUN

ONCOL

MB

RNMI

BE

Casey Moore United States

Gangjun Lei United States

Wilhem Leconet France

Donald L. Siegel United States

Ruby Alonso Cuba

Samuel Alsén Sweden

Maria Liljefors Sweden

Gregor Manukian United States

K A Smith United States

Pia M. Challita-Eid United States

Casey Moore United States

Olga Blomberg

315 ×1.0

IMMUN

253 ×0.9

ONCOL

191 ×1.1

MB

73 ×0.5

RNMI

53 ×0.9

BE

Citations per year, relative to Olga Blomberg Olga Blomberg (= 1×) peers Casey Moore

Countries citing papers authored by Olga Blomberg

Since Specialization

Citations

This map shows the geographic impact of Olga Blomberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Blomberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Blomberg more than expected).

Fields of papers citing papers by Olga Blomberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Blomberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Blomberg. The network helps show where Olga Blomberg may publish in the future.

Co-authorship network of co-authors of Olga Blomberg

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Blomberg. A scholar is included among the top collaborators of Olga Blomberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Blomberg. Olga Blomberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Blomberg, Olga, Kevin Kos, Lorenzo Spagnuolo, et al.. (2023). Neoadjuvant immune checkpoint blockade triggers persistent and systemic T _reg activation which blunts therapeutic efficacy against metastatic spread of breast tumors. OncoImmunology. 12(1). 2201147–2201147. 11 indexed citations

2.

Voorwerk, Leonie, Hannah Garner, Olga Blomberg, et al.. (2020). LBA10 Critical role of eosinophils during response to immune checkpoint blockade in breast cancer and other cancer types. Annals of Oncology. 31. S1142–S1142. 9 indexed citations

3.

Dougan, Michael, Jessica R. Ingram, Hee‐Jin Jeong, et al.. (2018). Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs. Cancer Immunology Research. 6(4). 389–401. 71 indexed citations

4.

Blomberg, Olga, Lorenzo Spagnuolo, & Karin E. de Visser. (2018). Immune regulation of metastasis: mechanistic insights and therapeutic opportunities. Disease Models & Mechanisms. 11(10). 99 indexed citations

5.

Ingram, Jessica R., Olga Blomberg, Mohammad Rashidian, et al.. (2018). Anti–CTLA-4 therapy requires an Fc domain for efficacy. Proceedings of the National Academy of Sciences. 115(15). 3912–3917. 125 indexed citations

6.

Ingram, Jessica R., Michael Dougan, Mohammad Rashidian, et al.. (2017). PD-L1 is an activation-independent marker of brown adipocytes. Nature Communications. 8(1). 647–647. 102 indexed citations

7.

Ingram, Jessica R., Olga Blomberg, Jonathan T. Sockolosky, et al.. (2017). Localized CD47 blockade enhances immunotherapy for murine melanoma. Proceedings of the National Academy of Sciences. 114(38). 10184–10189. 113 indexed citations

8.

Pilzecker, Bas, Colin E.J. Pritchard, Olga Blomberg, et al.. (2016). PrimPol prevents APOBEC/AID family mediated DNA mutagenesis. Nucleic Acids Research. 44(10). 4734–4744. 38 indexed citations

9.

Stulemeijer, I.J.E., Dirk De Vos, Onkar Joshi, et al.. (2015). Dot1 histone methyltransferases share a distributive mechanism but have highly diverged catalytic properties. Scientific Reports. 5(1). 9824–9824. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact